Plasma and salivary pharmacokinetics of caffeine in man.
about
Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man.Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the DrawbacksDNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of CancerPresence of caffeine reversibly interferes with efficacy of acupuncture-induced analgesiaCaffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports eventsThe pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease.Caffeine disposition in obesity.Hair follicles contribute significantly to penetration through human skin only at times soon after application as a solvent deposited solid in man.The margin of internal exposure (MOIE) concept for dermal risk assessment based on oral toxicity data - A case study with caffeine.Does long-term coffee intake reduce type 2 diabetes mellitus risk?Less Smad2 is good for you! A scientific update on coffee's liver benefits.Multiscale modeling reveals inhibitory and stimulatory effects of caffeine on acetaminophen-induced toxicity in humans.Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.Effects of time-release caffeine containing supplement on metabolic rate, glycerol concentration and performance.Caffeine and paraxanthine pharmacokinetics in the rabbit: concentration and product inhibition effects.The development and in vivo evaluation of a colon drug delivery system using human volunteers.Effects of exercise and thermal stress on caffeine pharmacokinetics in men and eumenorrheic women.Assessing caffeine exposure in pregnant women.Modulation of 3',5'-cyclic AMP homeostasis in human platelets by coffee and individual coffee constituents.A Randomized, Two-Way Crossover Study to Evaluate the Pharmacokinetics of Caffeine Delivered Using Caffeinated Chewing Gum Versus a Marketed Caffeinated Beverage in Healthy Adult Volunteers.Scientific Opinion on the substantiation of a health claim related to caffeine and increased alertness pursuant to Article 13(5) of Regulation (EC) No 1924/2006Administration of Caffeine in Alternate Forms.A descriptive systematic review of salivary TDM in neonates and infants.Correlation between thiopental induction dose and the volume of distribution of caffeine in human subjects.Prediction of thiopental induction dose based on caffeine volume of distribution.Use of salivary caffeine tests to assess the inducer effect of a drug on hepatic metabolism.Monitoring Caffeine in Human Saliva Using a Newly Developed ELISA
P2860
Q24541291-E8DA5570-C72F-4F07-865F-4CEA9701FF45Q26740559-0D27A93D-B40E-4870-873D-3C4C8B3677E7Q26776513-A40C1E0C-2A1F-4335-BDFF-601B3AAA496DQ33794389-FF18A646-2284-4B5B-9E9F-FEF52AEC62F4Q34357902-6B59829E-FFB9-4E84-AC44-E2B5724D62C8Q34397232-1115C054-19C8-42E2-B63A-9F3E7F564F65Q34446539-937F52E7-1A28-452E-8DE5-564869F2D77FQ35624593-344118AA-5F31-49C6-9D5F-2F667D0A52A6Q36306828-83DA3B58-10F6-4916-A512-3198E623A4B5Q37385927-A48EFC98-751A-497E-993E-F0E6DD3E34D2Q37554158-4830CFD2-82C0-4389-8D3A-D02A3B4F5EE0Q38994159-67E6D487-3862-4C8D-A4CF-D0276283E282Q39113148-3E693795-EA8B-4B03-858F-044C5B8AFB14Q40435772-611E08A9-BD20-4FF8-A778-E887DC2EF7CAQ41460169-8365E7D8-DCAA-44D0-8544-1E9CB067BF21Q44013722-449440FD-68BC-414D-ACE5-868C7E3CB590Q44138662-359ED7FC-0A5A-4FBF-8983-93D44516790CQ46709344-1FD98F9F-0723-4296-A9B7-254C4BAB33BFQ46835111-41F90156-E02D-46E3-AAD7-71EE46D5934FQ47150400-D49720FD-BA20-469B-AA8B-81C0607E23DBQ47154224-24344D66-C713-40B4-80FF-E8AA1680E0F4Q47549289-05A68FCA-2602-42F9-A8C2-9563BADF6870Q50016064-0AAA36E0-CF8F-4771-A1DA-8BF04C234084Q51812208-519E9AB8-5DFC-499A-ACEE-A4665E827538Q51827170-7F70570C-D093-4E8E-A411-1E35ED61570CQ53985559-D33DE031-6340-40D2-9061-FCF18BD79C6FQ58279301-600800F7-2ADF-431E-845E-9811EB277AE1
P2860
Plasma and salivary pharmacokinetics of caffeine in man.
description
1981 nî lūn-bûn
@nan
1981 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Plasma and salivary pharmacokinetics of caffeine in man.
@ast
Plasma and salivary pharmacokinetics of caffeine in man.
@en
Plasma and salivary pharmacokinetics of caffeine in man.
@nl
type
label
Plasma and salivary pharmacokinetics of caffeine in man.
@ast
Plasma and salivary pharmacokinetics of caffeine in man.
@en
Plasma and salivary pharmacokinetics of caffeine in man.
@nl
prefLabel
Plasma and salivary pharmacokinetics of caffeine in man.
@ast
Plasma and salivary pharmacokinetics of caffeine in man.
@en
Plasma and salivary pharmacokinetics of caffeine in man.
@nl
P2093
P356
P1476
Plasma and salivary pharmacokinetics of caffeine in man.
@en
P2093
H J Rogers
I D Bradbrook
L J Broughton
P J Morrison
P2888
P356
10.1007/BF00609587
P577
1981-01-01T00:00:00Z
P6179
1030080837